Riders · The University of Texas Southwestern Medical Center · Article III: Agencies of Education
Cell and Gene Therapy Center
Rider 8 in the 2026-27 Act, page III-220
Through the session
- 2024-25 Act Not in this version
- Introduced (Senate) Not in this version
- Introduced (House) Not in this version
- Senate substitute Not in this version
- House substitute Not in this version
- House passed Not in this version
- Conference New rider 8
- 2026-27 Act Unchanged rider 8
Pick any two steps to compare their wording.
What changed in the text
Conference → 2026-27 Act: the same text in both versions.
Removed words are struck through; added words are underlined. Sources: Conference · 2026-27 Act.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | Not in this version | |||
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | Not in this version | |||
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | Not in this version | |||
| Senate substituteCommittee Substitute for Senate Bill 1 | Not in this version | |||
| House substituteHouse Committee Substitute for Senate Bill 1 | Not in this version | |||
| House passedSenate Bill 1 as passed the second house | Not in this version | |||
| ConferenceConference Committee Report for Senate Bill 1 | 8 | New | New | Page III-196 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 8 | Unchanged | New | Page III-220 |
Full text of each wording
Conference, 2026-27 Act
Source, page III-220Cell and Gene Therapy Center. Out of funds appropriated above in Strategy D.2.2, Cell and Gene Therapy Center, $9,000,000 from the General Revenue Fund in fiscal year 2026 and $9,000,000 from the General Revenue Fund in fiscal year 2027 shall be used for the Center for Cell and Gene Therapy. Any unexpended balances as of August 31, 2026, are appropriated for the same purpose for the fiscal year beginning on September 1, 2026.